Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells (Q32107279)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells |
scientific article |
Statements
1 reference
Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells (English)
1 reference
Nimmanapalli R
1 reference
Porosnicu M
1 reference
Nguyen D
1 reference
Worthington E
1 reference
O'Bryan E
1 reference
Perkins C
1 reference
Bhalla K
1 reference
1 February 2001
1 reference
1 reference